Sort by

Send to

Choose Destination

Search results

Items: 6


The public health benefit of medicines: how it has been assessed in France? The principles and results of five years' experience.

Maison P, Zanetti L, Solesse A, Bouvenot G, Massol J; ISPEP group of the French National Authority for Health.

Health Policy. 2013 Oct;112(3):273-84. doi: 10.1016/j.healthpol.2013.04.007. Epub 2013 May 10.


[French Health Authority (HAS) Guidance: the post-registration studies on health technologies (drugs, medical devices and instruments): principles and methods].

Stamenkovic S, Solesse A, Zanetti L, Zagury P, Vray M; le groupe Intérêt de santé publique et études post-inscription (ISPEP).

Therapie. 2012 Sep-Oct;67(5):409-21. doi: 10.2515/therapie/2012065. Epub 2012 Dec 18. Review. French.


The French Observational Cohort of Usual Smokers (FOCUS) cohort: French smokers perceptions and attitudes towards smoking cessation.

Aubin HJ, Peiffer G, Stoebner-Delbarre A, Vicaut E, Jeanpetit Y, Solesse A, Bonnelye G, Thomas D.

BMC Public Health. 2010 Feb 26;10:100. doi: 10.1186/1471-2458-10-100.


Cost-effectiveness analysis of aldosterone blockade with eplerenone in patients with heart failure after acute myocardial infarction in the French context: the EPHESUS study.

de Pouvourville G, Solesse A, Beillat M.

Arch Cardiovasc Dis. 2008 Sep;101(9):515-21. doi: 10.1016/j.acvd.2008.09.001. Epub 2008 Nov 6.


Cost-effectiveness of atorvastatin in the prevention of cardiovascular events in diabetic patients: a French adaptation of CARDS.

Lafuma A, Colin X, Solesse A.

Arch Cardiovasc Dis. 2008 May;101(5):327-32. doi: 10.1016/j.acvd.2008.05.003. Epub 2008 Jun 24.


[Prevalence and description of treatment with intraocular pressure-lowering topical medications in continental France].

Delcourt C, Bron A, Baudouin C, Denis P, Nordmann JP, Renard JP, Rouland JF, Sellem E, Stephan M, Levrat F, Solesse A.

J Fr Ophtalmol. 2006 Dec;29(10):1098-106. French.

Items per page

Supplemental Content

Loading ...
Write to the Help Desk